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Introduction The Numerical Rating Scale (NRS) is 
frequently used to assess patient-reported breathlessness 
in both a research and clinical context. A subgroup of 
patients report average breathlessness as worse than their 
worst breathlessness in the last 24 hours (paradoxical 
average). The Peak/End rule describes how the most 
extreme and current breathlessness influence reported 
average. This study seeks to highlight the existence of a 
subpopulation who give ‘paradoxical averages using the 
NRS, to characterise this group and to investigate the 
explanatory relevance of the ‘Peak/End’ rule.
Methods Data were collected within mixed method 
face-to-face interviews for three studies: the Living with 
Breathlessness Study and the two subprotocols of the 
Breathlessness Intervention Service phase III randomised 
controlled trial. Key variables from the three datasets were 
pooled (n=561), and cases where participants reported 
a paradoxical average (n=45) were identified. These 
were compared with non-cases and interview transcripts 
interrogated. NRS ratings of average breathlessness were 
assessed for fit to Peak/End rule.
results Patients in the paradoxical average group had 
higher Chronic Respiratory Questionnaire physical domain 
scores on average p=0.042). Peak/End rule analysis 
showed high positive correlation (Spearman’s rho=0.756, 
p<0.001).
conclusions The NRS requires further standardisation 
with reporting of question order and construction of scale 
used to enable informed interpretation. The application of 
the Peak/End rule demonstrates fallibility of NRS-Average 
as a construct as it is affected by current breathlessness. 
Measurement of breathlessness is important for both 
clinical management and research, but standardisation and 
transparency are required for meaningful results.
IntroductIon
Dyspnoea is defined by the American 
Thoracic Society as ‘a subjective experience 
of breathing discomfort that consists of qual-
itatively distinct sensations that vary in inten-
sity’.1 2 Breathlessness accompanies many 
chronic conditions such as chronic obstruc-
tive pulmonary disease (COPD)3 and cancers 
of all types.4 5 It can have a profound effect 
on multiple aspects of quality of life.6 Patient 
assessment of breathlessness is fundamental 
to clinical management and research. There 
are growing calls for more routine assessment 
of breathlessness and a better understanding 
of the variation in reporting shown across 
groups of individuals.7 A range of tools are 
available such as the unidimensional Numer-
ical Rating Scale (NRS) and the broader 
Multidimensional Dyspnea Profile (MDP),8 
which assesses different domains of dyspnoea 
including emotional response.
The NRS, commonly used for self-reporting 
of subjective conditions, consists of a scale 
numbered 0–10, usually arranged vertically, 
anchored by a descriptive statement at each 
end and accompanied by a rating question9 
(see online supplementary file: appendix A). 
A higher score represents greater symptom 
severity. The NRS was initially developed 
for pain assessment, where it is recom-
mended,10 11 but has been adapted and 
recommended for breathlessness.9 12 13 In 
breathlessness, it is typically anchored with 0: 
‘Not breathless at all’ and 10: ‘Breathlessness 
as bad as you can imagine’. A variety of ques-
tions are asked, most commonly: ‘What is the 
worst your breathlessness has been over the 
last 24 hours?’ (NRS-Worst), ‘How has your 
breathlessness been over the last 24 hours on 
average?’ (NRS-Average) and ‘How is your 
breathlessness now?’(NRS-Now).
One criticism of the NRS is that it has 
not been sufficiently evaluated.9 In COPD, 
validation is based on comparison with 
visual analogue scale (VAS) ratings.14 
In patients with cancer, the most cited study 
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surveyed just 31 patients but, despite this, it showed that 
the precise rating question asked is important: NRS-Worst 
requires a smaller sample size to detect a change in 
breathlessness than NRS-Average, and both require less 
than VAS equivalents.15
Recent studies using the NRS to assess breathlessness, 
in line with current recommendations,9 12 13 16 noted a 
subset of participants who, paradoxically, rated NRS-Av-
erage as worse than NRS-Worst.
The ‘Peak/End’ rule is a leading psychological theory 
that offers an explanation for the now-established differ-
ences between perception of an experience as it takes place 
(moment-based reporting) and subsequent retrospec-
tive assessment of the same experience (memory-based 
reporting).17 Since NRS-Average relies on memory-based 
reporting, the ‘Peak/End’ rule is potentially relevant. 
Broadly, it states that a when recalling an event—whether 
positive or negative—only the ‘Peak’ (the most extreme 
experience) and the ‘End’18 are taken into account while 
the duration of the event is overlooked.
Methods
This paper seeks to highlight the existence of a subpop-
ulation who give paradoxical averages using the NRS, to 
characterise this group and to investigate the explanatory 
relevance of the ‘Peak/End’ rule.
Data were collected within mixed method face-to-face 
interviews for three studies: the Living with Breathless-
ness Study (LwB)19 and the two subprotocols of the 
Breathlessness Intervention Service (BIS) phase III 
randomised controlled trial (RCT).20 21 LwB recruited a 
population-based sample of well-characterised patients 
with advanced COPD and their carers to a mixed method 
interview study seeking to improve care and support. 
The BIS phase III RCT was a mixed method pragmatic 
fast-track single-blinded RCT to evaluate a palliative care 
breathlessness intervention involving two subprotocols: 
one for patients and carers living with malignant condi-
tions and one for non-malignant conditions.22 23
All three studies used NRS-Average, NRS-Worst and the 
Chronic Respiratory Questionnaire (CRQ; self-reported24 
for LwB and interviewer administered25 for BIS). Both 
patients and carers participated; carers assessed patient 
breathlessness.
Key variables from the three datasets were pooled, 
and cases where participants reported a paradoxical 
average were identified. Cases and non-cases were 
compared with age and sex (patients and carers) and 
CRQ physical and emotional domains (patients only). 
Fisher’s exact test was used for categorical variables, 
and the Mann-Whitney U test was used for continuous 
variables.
Interview transcripts of the NRS administration were 
available for the LwB Study only. From these, extracts 
relating to NRS administration were reviewed for those 
cases that gave paradoxical averages. These brief extracts 
were reviewed to identify potential explanations for the 
paradoxical averages both in terms of verbalised partici-
pant thought processes and the way in which the scales 
were administered by the interviewers, for example, 
verbal explanations given to participants.
An additional analysis was conducted to explore the 
relevance of the Peak/End rule. This was restricted to 
the BIS datasets as they included NRS-Now. All NRS ques-
tions were asked in reference to the last 24 hours so this 
can be considered the duration of the experience for all 
data points. NRS-Worst was taken to represent the ‘Peak’ 
within those 24 hours, while NRS-Now represents the end 
of the experience. The mean of NRS-Worst and NRS-Now 
was calculated for each participant to represent their 
expected assessment following the Peak/End rule. These 
means were plotted against NRS-Average as a memo-
ry-based participant-generated assessment of the same 
period to assess distribution and potential correlation. 
Spearman’s rank correlation coefficient was calculated. 
Quantitative analyses were performed using SPSS (V.23).
results
Of 662 pooled patients and carers, 101 were excluded 
due to missing data for at least one variable and 45 were 
identified as paradoxical average cases. Table 1 summa-
rises and compares the characteristics of cases and 
non-cases. Patients in the paradoxical average group had 
higher CRQ physical domain scores on average.
A review of transcripts from cases identified within the 
LwB Study provided insights on aspects participants, and 
interviewers, found difficult. There was confusion about 
how to use the scale and the direction of scoring. After 
discussion, one patient commented ‘I thought it was going 
up not down’ concluding ‘That question is crap [laugh] it’s 
badly written’ (LwB208-003). The transcripts also suggest 
how participants might be assessing average. When asked 
about their worst breathlessness in the last 24 hours 
(NRS-Worst), one patient responded: ‘not too bad at the 
minute because I haven’t been doing things’ (LwB302-022). 
This suggests that, for this participant, current breath-
lessness influenced their retrospective assessment. In 
another case, there was discussion of specific events that 
occurred the day before that might have been linked 
to worst breathlessness; however, this finding was not 
universal.
Interviewer administration of the NRS varied. Some-
times interviewers sought to guide participants’ under-
standing of ‘average’, using phrases such as ‘the good and 
the time it was the worst’ (LwB302-022) and ‘taking in the good 
and the bad’ (LwB400-013, LwB503-077 and LwB504-014). 
Furthermore, questions were asked in subtly, different 
ways with questions broken down into simpler parts:
I: … think about how you’ve been over the last 
24 hours - so from 11 o'clock yesterday morning.
P: Okay.
I: What’s the worst that your breathlessness has been, 
on that scale? (LwB208-003)
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Interviewers may also have had issues with the direc-
tionality of the scale. When one patient offered ‘3 or 4’ 
as an answer, the interviewer said they would record 4 
‘because I’m going to go on the side of caution’ (LwB503-077); 
this, however, represents a worse score. Another inter-
viewer queried ratings of average and worst that were the 
same but accepted a higher revised estimate for average.
Figure 1 presents the findings of the Peak/End rule 
analysis conducted on the BIS datasets. The monotonic 
association and high positive correlation (Spearman’s 
rho=0.756, p<0.001) shows a relationship between 
participant memory-based reporting and responses as 
predicted by the Peak/End rule. This strongly suggests 
that the Peak/End rule applies in this context and there-
fore that average breathlessness reporting is influenced 
by current breathlessness at the time of asking.
dIscussIon
We identified a group of respondents who reported their 
average breathlessness as worse than their worst breath-
lessness in the past 24 hours. This was not just a patient-re-
porting problem but also one for some carers.
 ► Patients in this group had a higher CRQ physical do-
main score.
 ► Participants in this study have a high median age, 
while the NRS is shown to be more reliable in young-
er participants.
 ► Current breathlessness affected reporting of average 
breathlessness indicating the Peak/End rule applied.
 ► There were administration difficulties in using the 
scale in terms of directionality, interviewer variability 
and question structuring.
The existence of this group raises questions for the 
validity and utility of the NRS for symptom assessment 
without clear guidance. While the population we iden-
tified is small, it represents only those cases where 
confusion surrounding the scale resulted in paradox-
ical answers; the implication is that there may have been 
others who struggled with the scale but whose answers 
appeared valid. There are several possible explanations 
for our findings.
the nrs itself
There is little standardisation in how the NRS is used, in 
terms of both its design and administration. In terms of 
design, it is reassuring that, for VAS scales, orientation 
Table 1 Characteristics and comparison of cases and non-cases of paradoxical average
Participants
Non-cases of paradoxical 
average (average≤worst)
Cases of paradoxical 
average (average>worst) p Value
Patients n=350 n=21
Patient age, median (IQR) 72 (65–79) 70 (64–78) 0.450
Patient sex, n (%)
  Male 201 (57) 9 (43) 0.257
  Female 149 (43) 12 (57)
CRQ* physical domain, median (IQR) 2.93 (2.11–3.78) 3.53 (2.78–3.89) 0.042
CRQ* emotional domain, median (IQR) 4.27 (3.36–5.27) 4.2 (3.73–4.48) 0.876
Carers n=166 n=24
Carer age, median (IQR) 68 (60–73) 67 (55–74) 0.815
Carer sex, n (%)
  Male 44 (27) 8 (33) 0.472
  Female 122 (74) 16 (67)
*Higher CRQ score reflects better health-related quality of life. LwB Study used the self-report version of the CRQ,24 whereas the two BIS 
RCT subprotocols used the interviewer administered version.25
BIS, Breathlessness Intervention Service; CRQ, Chronic Respiratory Questionnaire; LwB, Living with Breathlessness Study; RCT, randomised 
controlled trial.
Figure 1 Predicted peak/end assessment against 
reported average breathlessness. NRS, Numerical Rating 
Scale.
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appears not to matter for scales increasing left to right or 
up the page,26 and the NRS has been shown to be more 
reliable with patients younger than those in our samples 
when rating ‘peak’ breathlessness.16
In terms of administration, the NRS has been found to 
have the best response rate among established tools (even 
with over half returned incomplete in one study)27 and is 
recommended for clinical use because it is preferred by 
patients28; however, it is possible that these tools place an 
unexpected burden on patients. NRS questions are more 
complex than they at first appear. For example, ‘What 
is the worst your breathlessness has been over the last 
24 hours?’ is not always asked using this precise form of 
words but rather split so that the patient is first directed to 
think about the last 24 hours and then about their worst 
breathlessness during that period. It could be argued 
that the first part evokes a similar intuitive construct to 
asking ‘average’ or ‘bother’ and subsequently asking 
worst represents changing the participant’s focus. Papers 
rarely report how the scale is introduced to participants. 
In the studies used for our analysis, a version of the NRS 
worsening down the page was used for consistency with 
the layouts of the Medical Research Council dyspnoea 
scale and Modified Borg Scale, which participants also 
completed; however, the effect of directionality on 
responses, especially those that were revised on ques-
tioning, is a topic for further research.
Assessment of breathlessness at worst
Rating breathlessness at worst might seem the more intu-
itive of the two NRS questions administered (indeed, it 
has the lowest within-subject variability compared with 
the other questions13). It should be re-emphasised that 
a timeframe of the last 24 hours was used since reporting 
breathlessness has been shown to be consistent over the 
short timeframe of an emergency department visit but 
systematically biased when retested 4–6 weeks later when 
using the MDP.29 While there is a natural parallel to 
worst breathlessness, hospital admission has the strength 
of being a predefined event, and we have argued that 
patients may not be thinking of their breathlessness ‘at 
worst’ when answering about worst breathlessness.
One strategy to reduce errors may be to direct partici-
pants to think of and describe the worst experience in the 
last 24 hours and then rate it while looking at a scale show 
card. Examination of transcripts suggests that in some 
cases interviewers guided thinking in this way. This is akin 
to cognitive interviewing or think-aloud approaches30 and 
may help ensure the worst moment is not overlooked. 
Any attempt at using such techniques should still be stan-
dardised and reported as far as possible.
Assessment of breathlessness on average
In asking participants to report averages, we are making 
assumptions that participants:
 ► understand the concept of average
 ► can compute an average that bears faithful relation to 
their experience
 ► and that assessment is repeatable and not influenced 
by factors relating to the asking of the question.
Wilcock et al15 reported that asking patients to assess 
their ‘bother over the past 24 hours’ gave a very similar 
mean result to asking ‘average breathlessness over past 
24 hours’. While this does not explicitly support the 
validity of the first assumption, the similarity in the means 
suggests the same construct is being assessed in both. 
Regardless of whether the term ‘average’ is understood 
in a mathematical sense, there seems to be an intuitive 
way in which participants interpret it and weigh a period 
of experience. If the same concept is assessed regardless, 
then it is irrelevant whether the concept of average is 
understood and furthermore this is outweighed by the 
known problems with ratings of past experience.
The application of the ‘Peak/End’ rule demonstrates 
the fallibility of memory-based reporting suggesting 
NRS-Average relies on the Peak and End, rather than 
reflecting a true average. Thus, what is being measured 
may not be what researchers or clinicians intend. This 
finding builds on research showing the validity of the 
‘Peak/End’ rule in simulated breathlessness.31 Further-
more, while the rule may be time limited, the last 24 hours 
addressed in our study are well within the suggested 
boundary of 3 weeks.32 A corollary of the Peak/End rule 
is that experiences that are more variable are likely to be 
rated as more extreme overall since the ‘Peak’ is likely to 
be higher. This has been shown in patients with chronic 
pain.33
The ‘End’ is of interest as it is reasonable to assert 
that current breathlessness may act as a surrogate for 
this and is also widely measured. The construct validity 
of average breathlessness is therefore questionable. The 
effect of current breathlessness may be less important 
in a research setting as there may be greater consistency 
and control over the timing of assessments: in the studies 
used here, all respondents had been sitting for at least 
15 minutes. A busy clinical environment is likely to be 
more variable. In outpatients, clinicians could reasonably 
usually avoid asking ‘now’ as this is likely context depen-
dent and needs to be tightly constrained in reference to 
rest or exertion34; they may instead use worst or average, 
when they ask at all, but our findings suggest that when 
using NRS-Average, breathlessness ‘now’ may still play a 
role. A further area of investigation might relate to other 
temporal constructs used for breathlessness assessment 
such as ‘usual’,14 although the latter may still suffer from 
the same Peak/End rule issue.
Assessing both
Asking multiple questions may compound confusion, 
especially when some questions appear to have multiple 
parts. The order in which questions are asked is not 
standardised, but order may affect answers given by 
directing participants to think of ‘worst’ or ‘current’ as 
group.bmj.com on October 17, 2017 - Published by http://bmjopenrespres.bmj.com/Downloaded from 
Wade J, et al. BMJ Open Resp Res 2017;4:e000235. doi:10.1136/bmjresp-2017-000235 5
Open Access
benchmarks. Conversely, one could argue that asking 
more questions allows participants to become more 
aware of the nuance of the questions.
study limitations
Educational level and cognitive function (eg, due to 
suboptimal oxygen levels) may play a role in how partic-
ipants answer rating questions; however, these data were 
only available for the LwB Study making the sample too 
small to address this hypothesis.
Furthermore, NRS administration data were only avail-
able as transcriptions; thus, it was not always possible to 
tell the extent to which interviewers used the provided 
NRS show cards. We cannot, therefore, comment on the 
extent to which show cards may help.
recommendations
The findings of this study suggest care should be employed 
in using any scale or tool; even apparently simple ques-
tions and response scales can be more complex to process 
than they appear. Responses can be influenced by many 
factors, and for this reason, we would recommend:
 ► establishment of the optimal order of questions where 
multiple questions are used
 ► standardisation of NRS administration and order 
where multiple questions are used
 ► reporting that standard rules and design have been 
used, or provision of a copy of the scale used
 ► further research into the effect of current breathless-
ness and situation on retrospective reporting (eg, by 
asking average breathlessness at the beginning and 
end of clinic consultations)
 ► a think-aloud study exploring thought processes par-
ticipants go through when using the NRS to optimise 
its design.
conclusIon
Breathlessness is fundamental to quality of life and so to 
clinical practice; it is increasingly recognised as an impor-
tant predictor of outcome making routine assessment in 
everyone desirable.7 Efforts to improve clinical awareness 
and measurement of breathlessness have led to calls to 
recognise a clinical syndrome of chronic breathlessness.35 
To capitalise on increased clinical awareness validity, 
standardisation and transparency in breathlessness meas-
urement are essential. The NRS is a validated and highly 
recommended scale for breathlessness measurement, 
but this paper highlights that it requires care in choice 
of design and use. The application of the Peak/End rule 
demonstrates fallibility of NRS-Average as a construct 
that has implications for its utility.
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